Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma
暂无分享,去创建一个
Wei Zhang | Yang Zhang | L. Gong | Shaojun Zhu | Yan-hong Li | Xuxia Wang | Xiu-juan Han | M. Lan | L. Yao
[1] T. Asselah,et al. Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[2] J. Salmerón,et al. Risk Factors for Liver Disease and Associated Knowledge and Practices Among Mexican Adults in the US and Mexico , 2012, Journal of Community Health.
[3] I. Tolmane,et al. The prevalence of viral hepatitis C in Latvia: a population-based study. , 2011, Medicina.
[4] Yanning Liu,et al. [Research advances on treatment of hepatitis C infection based on RNA interference and microRNA modulation]. , 2011, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.
[5] R. Chung,et al. Viral hepatocarcinogenesis , 2010, Oncogene.
[6] K. Matschke,et al. Prevention of ischemia/reperfusion-induced accumulation of matrix metalloproteinases in rat lung by preconditioning with nitric oxide. , 2009, The Journal of surgical research.
[7] Huamin Wang,et al. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. , 2009, Pathology, research and practice.
[8] J. Tang,et al. Overexpression of HAb18G/CD147 promotes invasion and metastasis via α3β1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways , 2008, Cellular and Molecular Life Sciences.
[9] J. Goedert,et al. Aflatoxin Exposure and Viral Hepatitis in the Etiology of Liver Cirrhosis in The Gambia, West Africa , 2008, Environmental health perspectives.
[10] V. Gurtsevitch. Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis , 2008, Biochemistry (Moscow).
[11] T. Kanekura,et al. Inhibition of CD147 Gene Expression via RNA Interference Reduces Tumor Cell Proliferation, Activation, Adhesion, and Migration Activity in the Human Jurkat T-Lymphoma Cell Line , 2008, Cancer investigation.
[12] Ming‐Lung Yu,et al. Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C‐coinfected patients , 2007, Journal of gastroenterology and hepatology.
[13] P. Galle,et al. Hepatitis viruses: live and let die , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[14] Juan Tang,et al. βig-h3 Is Involved in the HAb18G/CD147-Mediated Metastasis Process in Human Hepatoma Cells , 2007 .
[15] C. Tzao,et al. Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[16] G. Sauter,et al. High incidence of EMMPRIN expression in human tumors , 2006, International journal of cancer.
[17] H. Iwasaki,et al. Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression , 2006, Pathology international.
[18] M. Bukrinsky,et al. Dealing with the family: CD147 interactions with cyclophilins , 2006, Immunology.
[19] Ding‐Shinn Chen,et al. Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections. , 2005, Journal of the Formosan Medical Association = Taiwan yi zhi.
[20] R. Panettieri,et al. Cyclic mechanical strain‐induced proliferation and migration of human airway smooth muscle cells: role of EMMPRIN and MMPs , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] M. Hemler,et al. Metabolic Activation-related CD147-CD98 Complex*S , 2005, Molecular & Cellular Proteomics.
[22] R. Wyman,et al. Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular architecture , 2005, Journal of Cell Science.
[23] M. Manns,et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. , 2005, Cancer research.
[24] Li Yan,et al. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression , 2005, Thrombosis and Haemostasis.
[25] Francesco Donato,et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.
[26] Josepa Ribes,et al. Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.
[27] Wei Tang,et al. Links between CD147 function, glycosylation, and caveolin-1. , 2004, Molecular biology of the cell.
[28] M. Manns,et al. Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular Carcinoma , 2004, Clinical Cancer Research.
[29] J. Goedert,et al. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa , 2004, Hepatology.
[30] Yi Ren,et al. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. , 2004, Chinese medical journal.
[31] A. Berner,et al. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma , 2004, Clinical & Experimental Metastasis.
[32] K. Okada,et al. Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. , 2003, Cancer letters.
[33] T. Major,et al. Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Is Induced Upon Monocyte Differentiation and Is Expressed in Human Atheroma , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[34] G. Colucci,et al. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection , 2002, American Journal of Gastroenterology.
[35] C. Abbott,et al. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. , 2002, The American journal of pathology.
[36] B. Toole,et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. , 2001, The American journal of pathology.
[37] N. Ohuchi,et al. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast , 2001, International journal of cancer.
[38] A. Barclay,et al. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression , 2000, The EMBO journal.
[39] Rongsong Li,et al. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. , 2000, Cancer research.
[40] J. Sipley,et al. Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion* , 1999, The Journal of Biological Chemistry.
[41] R. Cardiff,et al. CD44v3,8–10 is involved in cytoskeleton‐mediated tumor cell migration and matrix metalloproteinase (MMP‐9) association in metastatic breast cancer cells , 1998 .
[42] R. Cardiff,et al. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. , 1998, Journal of cellular physiology.
[43] F. Berditchevski,et al. Generation of Monoclonal Antibodies to Integrin-associated Proteins , 1997, The Journal of Biological Chemistry.
[44] C. Gilles,et al. Tumor Collagenase Stimulatory Factor (TCSF) Expression and Localization in Human Lung and Breast Cancers , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[45] F. Berditchevski,et al. Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6. , 1997, The Journal of biological chemistry.
[46] H. Guo,et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. , 1995, Cancer research.
[47] K. Kenyon,et al. Distribution of collagenase and cell types in sterile ulceration of human corneal grafts , 1989, Acta ophthalmologica. Supplement.
[48] A. Eisen,et al. Collagenase in human cornea: immunologic localization. , 1980, Archives of ophthalmology.